{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:34:37Z","timestamp":1784010877288,"version":"3.55.0"},"reference-count":43,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T00:00:00Z","timestamp":1215388800000},"content-version":"vor","delay-in-days":2672,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2001,3,14]]},"abstract":"<jats:p>The PFA\u2010100<jats:sup>\u00ae<\/jats:sup> (platelet function analyser) is a relatively new tool for the investigation of primary haemostasis. Recent studies have shown its utility in monitoring antiplatelet therapy (including aspirin) and as a screening tool for investigating possible von Willebrand disease (vWD) and various platelet disorders. More recently, the PFA\u2010100<jats:sup>\u00ae<\/jats:sup> has been shown to be of value in monitoring DDAVP therapy in both vWD and platelet disorders. This paper reviews current findings, details the utility of the PFA\u2010100<jats:sup>\u00ae<\/jats:sup> for some of these purposes, as well as reviewing analytical variables that may complicate the interpretation of results. The author highlights the benefits, as well as noting the limitations, of its use. Ultimately, the greatest strengths of the PFA\u2010100<jats:sup>\u00ae<\/jats:sup> are its simplicity in use and excellent sensitivity to particular haemostatic disturbances such as vWD, platelet disorders and platelet\u2010affecting medication. However, because it is thus a \u2018global\u2019 test system, this also creates a significant limitation, as the PFA\u2010100<jats:sup>\u00ae<\/jats:sup> is not specific for, nor predictive of, any particular disorder. However, utilized appropriately, the PFA\u2010100<jats:sup>\u00ae<\/jats:sup> can be considered a worthwhile addition to any haemostasis laboratory involved in the diagnosis or therapeutic\u2010monitoring of bleeding disorders including vWD and platelet\u2010dysfunctions. This review should be of value to both haemostasis scientists and clinical specialists.<\/jats:p>","DOI":"10.1046\/j.1365-2516.2001.00486.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T23:02:40Z","timestamp":1047423760000},"page":"170-179","source":"Crossref","is-referenced-by-count":100,"title":["Utility of the PFA\u2010100<sup>\u00ae<\/sup> for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations"],"prefix":"10.1111","volume":"7","author":[{"given":"E. J.","family":"Favaloro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,7,7]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"HuttonRA&LudlamCA.Platelet function testing.Association of Clinical Pathologists BroadsheetNo. 122 1989."},{"key":"e_1_2_6_3_2","unstructured":"FrojmovicM.Biorheology.Report of the 1999 ISTH SSC Biorheology meetingURL:http:\/\/www.med.unc.edu\/isth\/99biorheology.html\/"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1055\/s-0032-1313612","article-title":"Description of an in vitro platelet function analyser: PFA\u2010100\u00ae","volume":"21","author":"Kundu SK","year":"1995","journal-title":"Semin Thromb Hemost"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-0032-1313613","article-title":"Preliminary data from a field trial of the PFA\u2010100\u00ae system","volume":"21","author":"Mammen EF","year":"1995","journal-title":"Semin Thromb Hemost"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01660.x"},{"key":"e_1_2_6_7_2","first-page":"661","article-title":"A simple assay for platelet\u2010mediated hemostasis in flowing whole blood (PFA\u2010100): reproducibility and effects of sex and age","volume":"44","author":"Sestito A","year":"1999","journal-title":"Cardiologia"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00656.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996050"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996051"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996038"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0162-3109(99)00147-2"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0049-3848(97)00115-1"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0049-3848(99)00236-4"},{"key":"e_1_2_6_15_2","first-page":"439","article-title":"Effect of unfractionated and low\u2010molecular\u2010weight heparin on platelet aggregation and in vitro bleeding time in dogs","volume":"106","author":"Nimmerfall K","year":"1999","journal-title":"DTW Dtsch Tierarztl Wochenschr"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/107602969900500209"},{"key":"e_1_2_6_17_2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0037-1613805","article-title":"Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA\u2010100","volume":"83","author":"Homoncik M","year":"2000","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613974"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1997.00639.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.4.1325"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-995840"},{"key":"e_1_2_6_22_2","first-page":"452","article-title":"Clinical evaluation of platelet function analyzer PFA\u2010100 in dogs","volume":"111","author":"Keidel A","year":"1998","journal-title":"Berl Munch Tierarztl Wochenschr"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199901000-00004"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199911)62:3<165::AID-AJH6>3.0.CO;2-C"},{"key":"e_1_2_6_25_2","first-page":"584","article-title":"Inhibition of platelet aggregation after intake of acetylsalicylic acid detected by a platelet function analyzer (PFA\u2010100)","volume":"37","author":"Feuring M","year":"1999","journal-title":"Int J Clin Pharmacol Ther"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1055\/s-0037-1613859","article-title":"Use of the PFA\u2010100 apparatus to assess platelet function in patients undergoing PTCA during and after infusion of cE3 Fab in the presence of other antiplatelet agents","volume":"83","author":"Hezard N","year":"2000","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1053\/cp.1999.v66.a101063"},{"key":"e_1_2_6_28_2","first-page":"614","article-title":"Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA\u2010100): influence of hematocrit elevation","volume":"84","author":"Escolar G","year":"1999","journal-title":"Haematologica"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1010230"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1177\/107602969600200404"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2001.00487.x"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0049-3848(99)00152-8"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0049-3848(99)00102-4"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614626"},{"key":"e_1_2_6_35_2","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/blood.V93.11.3578","article-title":"Low platelet\u2003alpha2, beta1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system","volume":"93","author":"Di Paola J","year":"1999","journal-title":"Blood"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613973"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01604.x"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-8652(200004)63:4<197::aid-ajh6>3.3.co;2-u"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1054\/blre.1999.0116"},{"key":"e_1_2_6_40_2","first-page":"1","article-title":"Guidelines for the diagnosis and management of von Willebrand Disease","volume":"3","author":"von Willebrand Working Party of the United Kingdom Haemophilia Centre Directors\u2019 Organisation","year":"1995","journal-title":"Haemophilia"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614035"},{"key":"e_1_2_6_42_2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-0037-1614097","article-title":"von Willebrand factor ristocetin cofactor activity correlates with platelet function in a high shear stress system","volume":"84","author":"Veyradier A","year":"2000","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/112.5.712"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050542"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2516.2001.00486.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2516.2001.00486.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2516.2001.00486.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:19:17Z","timestamp":1697588357000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2516.2001.00486.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3,14]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,3,14]]}},"alternative-id":["10.1046\/j.1365-2516.2001.00486.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2516.2001.00486.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3,14]]}}}